Navigation Links
Newly Published Case Series Demonstrates the Karius Test’s Effectiveness for Monitoring Infections in Stem-Cell Transplant Patients at Risk of Infections
Date:12/13/2018

Karius, Inc., a life sciences company transforming infectious disease diagnostics with genomics, announced today the results of an ongoing clinical study of adult patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT). The early findings showed that the Karius® Test, a non-invasive blood test that detects pathogen cell-free DNA in plasma, is an effective infectious disease diagnostic that can quickly and accurately detect infections early and potentially help guide therapy in these patients.

Allo-HSCT is a life-saving treatment for patients with high-risk leukemia. However, it increases the risk of infections, which can cause significant complications and death in this population [1]. Diagnosing infections in allo-HSCT patients is challenging due to their susceptibility to uncommon pathogens and atypical clinical presentations of disease. Current laboratory methods are also frequently unable to establish a clear diagnosis for an infection. [1,2]

Dr. Monica Fung, UCSF, first author of the study, says, “We often struggle to make a diagnosis in patients with stem cell transplants. Their infections don’t manifest with the typical symptoms you see in healthy individuals. What is exciting about the Karius Test is its ability to test a really broad range of pathogens quickly.”

The publication describes three unique cases that highlight the benefits of a novel, non-invasive, rapid diagnostic tool for the management of patients at high risk of infections. These patients are enrolled in the DISCOVER (Diagnosis of Infection in Stem Cell Transplant Patients OVER Time) study at UCSF. In these patients, the Karius Test had the potential to detect bacterial infections prior to initial symptoms or conventional tests.

Dr. Peter Chin-Hong and Dr. Aaron Logan from UCSF were lead authors of the study. Dr. Chin-Hong says: “The timing of a diagnosis for an infection in immunocompromised patients is very important, every minute matters. These findings show the utility of the test to quickly and accurately detect infections with a non-invasive method.”

One case showed that the Karius Test detected Chlamydia trachomatis 7 days prior to initial symptoms and 30 days prior to standard microbiologic diagnosis. In another case, the Karius Test detected Staphylococcus aureus even after the patient had been on antibiotics and before conventional microbiology tests identified an infection. These findings suggest the potential value of the Karius Test to help guide therapy and monitor treatment to help improve outcomes.

“This first look at the results from the DISCOVER trial shows the promise of the Karius Test in identifying pathogens in stem-cell transplant patients prior to conventional microbiology tests. This could lead to earlier targeted treatment in these high-risk patients,” says Dr. David Hong, VP of Medical Affairs and Clinical Development at Karius.

The study is available on the Open Forum Infectious Diseases Journal’s website at https://academic.oup.com/ofid/advance-article/doi/10.1093/ofid/ofy301/5184895

1.    Wingard JR, Hsu J, Hiemenz JW. Hematopoietic Stem Cell Transplantation: An Overview of infection risks and epidemiology.
2.    Serody JS, Berrey MM, Albritton K, et al. Utility of obtaining blood cultures in febrile neutropenic patients undergoing bone marrow transplantation. Bone Marrow Transplant, 2000; 26: 533-8.

About Karius, Inc.
Karius is a life sciences company focused on transforming infectious disease diagnostics with genomics and data through the innovative use of next-generation sequencing to analyze microbial cell-free DNA. The Karius laboratory is CLIA-certified and CAP-accredited to perform high-complexity clinical laboratory testing. The company’s genomics platform and clinically-curated pathogen database deliver deep insight into the microbial landscape, providing clinicians with a comprehensive, quantitative test capable of identifying more than a thousand pathogens directly from blood and helping industry accelerate drug development. For more information, visit kariusdx.com and follow us on Twitter at @kariusdx.

Read the full story at https://www.prweb.com/releases/newly_published_case_series_demonstrates_the_karius_tests_effectiveness_for_monitoring_infections_in_stem_cell_transplant_patients_at_risk_of_infections/prweb15983820.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related medicine technology :

1. Upsher-Smith Introduces Newly Redesigned Corporate Website
2. Worldwide Orthopaedic Product Sales Reached $43.1 Billion in 2012, States ORTHOWORLDs Newly-released Orthopaedic Industry Report
3. Ferring Pharmaceuticals Inc. Announces $1M Donation to the Alliance for Fertility Preservation, a Newly Formed Charitable Organization
4. aTyr Pharma Completes $49 Million Financing to Advance a Therapeutic Pipeline for Rare Autoimmune Diseases from a Newly Discovered Class of Proteins, Physiocrines
5. Arthritis in Dogs is Now Treatable with a Newly-Released High Quality Supplement from Pear & Berry
6. Newly-Published Study Concludes Stretta May Be More Desirable GERD Treatment than Chronic PPI Use or Anti-Reflux Surgery in Some Patients
7. Medbox Focuses on Newly Emerging Medical and Recreational Marijuana States
8. EMD Serono Exclusive Supporter of Newly Launched Multiple Sclerosis Resource Centre
9. Medbox Targets Newly Emerging $1.3 Billion Canadian Medical Marijuana Market
10. Among Newly Diagnosed Type 2 Diabetes Patients, DPP-IV Inhibitors are the Leading Oral Therapies After Standard Metformin and Sulfonylurea
11. Lamotrigine is One of the Most Commonly Prescribed Drugs Among Newly Diagnosed Bipolar Disorder Patients in the United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2019)... ... January 21, 2019 , ... Tooth loss can be caused ... risk factors, says a March 7, 2013 Web MD article, “Tooth Loss Associated ... just under 40 countries showed links between the loss of teeth and the ...
(Date:1/20/2019)... ... 2019 , ... The Icahn School of Medicine at Mount ... sodium for the treatment of mucopolysaccharidosis (MPS), with Australia-based company Paradigm Biopharmaceuticals Ltd. ... a group of 11 lysosomal storage diseases, metabolic disorders caused by genetic defects ...
(Date:1/20/2019)... ... January 19, 2019 , ... California firefighter Trent Knuckles is the ... Sweepstakes. He won one of three prize packages that included a check for $2,250 ... 5.11 tactical gear that included a carry bag, backpack, RAID Glasses, flashlight, hats and ...
Breaking Medicine Technology:
(Date:1/14/2019)... ... January 14, 2019 , ... Modere ... personal-care products with a presence worldwide, today announced that it built on 2017’s ... Modere sales grew by double-digits in North America, by more than five times ...
(Date:1/14/2019)... ... January 15, 2019 , ... Jeffery Nelson, M.D., FACS, ... Institute for Digestive Health & Liver Disease at Mercy Medical Center , ... designed instrument known as a suction hemorrhoid ligator is used with the procedure; ...
(Date:1/14/2019)... ... ... Trees can be overweight too! Giroud Tree and Lawn ... a great time to clean things up on the property! , Health and Safety ... windy or icy storms. The crown of the tree should be pruned to reduce ...
(Date:1/14/2019)... , ... January 14, 2019 , ... Dr. Kaveh Kanani D.D.S . is the ... Woodland Hills. This well established general dentist has recently unveiled an inventive method ... missing teeth. When a tooth is missing for an extended period of time, the jawbone ...
(Date:1/13/2019)... ... January 12, 2019 , ... New Vitae Wellness and Recovery ... to the community, providing a variety of residential behavioral health and outpatient services. ... Vitae co-founder and owner Adam Devlin. “We are continuing to build recovery ...
Breaking Medicine News(10 mins):